Literature DB >> 6610203

Clinical appearance at diagnosis of ulcerative colitis and Crohn's disease in a regional patient group.

H Both, K Torp-Pedersen, S Kreiner, C Hendriksen, V Binder.   

Abstract

A regional patient group comprising 783 patients with ulcerative colitis (UC) and 185 patients with Crohn's disease (CD) diagnosed during the period 1960 to 1978 was analysed in accordance with clinical appearance at diagnosis. Of the UC patients, 16% showed total colonic involvement, 41% substantial colonic involvement, and 41% rectal affection only. The disease extent was positively correlated to the degree of activity but not to the age or sex of the patients. 70% of the patients were in moderately or very active stage of disease, 28% in slightly active stage, and 2% inactive at the time of diagnosis. 43% of the patients had experienced weight loss, 27% fever, and 53% abdominal pains in their initial attack of the disease. Immunological manifestations were present in 13%. Of the CD patients 31% had small-bowel localization only, 28% large bowel only, 36% ileocolonic affection, and 5% other combinations. Patients with ileal involvement were significantly younger than patients with colonic involvement. There was no sex difference in accordance with the localization of Crohn's disease. 71% of the patients were in moderately or very active stage of disease and 29% in low activity at diagnosis. The intestinal symptoms were independent of the sex and age of the patients, whereas abdominal pains were present significantly more frequently in younger age groups. In all, 76% of the patients experienced abdominal pains, 34% fever, and 54% weight loss. Immunological symptoms from joints, skin, or eyes were present in 12% of the patients.

Entities:  

Mesh:

Year:  1983        PMID: 6610203     DOI: 10.3109/00365528309182127

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  12 in total

1.  Linkage between genotype and immunological phenotype in Crohn's disease.

Authors:  Gwenny M Fuhler; Kaushal Parikh; C Janneke van der Woude; Maikel P Peppelenbosch
Journal:  Ann Transl Med       Date:  2015-09

2.  Prognostic indicators and clinical course in proctosigmoiditis.

Authors:  L D Juby; D E Long; M F Dixon; A T Axon
Journal:  Int J Colorectal Dis       Date:  1990-12       Impact factor: 2.571

3.  Altered expression of mucins throughout the colon in ulcerative colitis.

Authors:  J E Smithson; A Campbell; J M Andrews; J D Milton; R Pigott; D P Jewell
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

4.  Incidence of inflammatory bowel disease in north west Greece: rarity of Crohn's disease in an area where ulcerative colitis is common.

Authors:  E V Tsianos; C N Masalas; M Merkouropoulos; G N Dalekos; R F Logan
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

5.  Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease.

Authors:  Avegail Flores; Ezra Burstein; Daisha J Cipher; Linda A Feagins
Journal:  Dig Dis Sci       Date:  2015-03-24       Impact factor: 3.199

6.  [Initial symptoms, extra-intestinal manifestations and course of pregnancy in chronic inflammatory bowel diseases].

Authors:  H C Rath; T Andus; I Caesar; J Schölmerich
Journal:  Med Klin (Munich)       Date:  1998-07-15

7.  Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention.

Authors:  P M Choi; M P Zelig
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

8.  Long term prognosis in ulcerative colitis--based on results from a regional patient group from the county of Copenhagen.

Authors:  C Hendriksen; S Kreiner; V Binder
Journal:  Gut       Date:  1985-02       Impact factor: 23.059

9.  Prognosis in Crohn's disease--based on results from a regional patient group from the county of Copenhagen.

Authors:  V Binder; C Hendriksen; S Kreiner
Journal:  Gut       Date:  1985-02       Impact factor: 23.059

10.  Severe gastrointestinal hemorrhage in Crohn's disease.

Authors:  J R Robert; D B Sachar; A J Greenstein
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.